WBA logo

Walgreens Boots Alliance (WBA) EBITDA

annual EBITDA:

-$11.28B-$8.70B(-336.79%)
August 31, 2024

Summary

  • As of today (May 29, 2025), WBA annual EBITDA is -$11.28 billion, with the most recent change of -$8.70 billion (-336.79%) on August 31, 2024.
  • During the last 3 years, WBA annual EBITDA has fallen by -$16.15 billion (-331.44%).
  • WBA annual EBITDA is now -234.89% below its all-time high of $8.36 billion, reached on August 31, 2018.

Performance

WBA EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherWBAincome statement metrics

quarterly EBITDA:

-$3.51B-$3.71B(-1777.51%)
February 28, 2025

Summary

  • As of today (May 29, 2025), WBA quarterly EBITDA is -$3.51 billion, with the most recent change of -$3.71 billion (-1777.51%) on February 28, 2025.
  • Over the past year, WBA quarterly EBITDA has increased by +$8.86 billion (+71.64%).
  • WBA quarterly EBITDA is now -179.68% below its all-time high of $4.40 billion, reached on November 30, 2021.

Performance

WBA quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherWBAincome statement metrics

TTM EBITDA:

-$2.57B+$8.86B(+77.50%)
February 28, 2025

Summary

  • As of today (May 29, 2025), WBA TTM EBITDA is -$2.57 billion, with the most recent change of +$8.86 billion (+77.50%) on February 28, 2025.
  • Over the past year, WBA TTM EBITDA has increased by +$8.66 billion (+77.11%).
  • WBA TTM EBITDA is now -127.69% below its all-time high of $9.29 billion, reached on February 28, 2022.

Performance

WBA TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherWBAincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

WBA EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-336.8%+71.6%+77.1%
3 y3 years-331.4%-323.2%-127.7%
5 y5 years-260.0%-311.7%-141.0%

WBA EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-276.9%at low-323.2%+71.6%-127.7%+77.5%
5 y5-year-260.0%at low-179.7%+71.6%-127.7%+77.5%
alltimeall time-234.9%at low-179.7%+71.6%-127.7%+77.5%

WBA EBITDA History

DateAnnualQuarterlyTTM
Feb 2025
-
-$3.51B(-1777.5%)
-$2.57B(-77.5%)
Nov 2024
-
$209.00M(-185.3%)
-$11.43B(+1.3%)
Aug 2024
-$11.28B(+336.8%)
-$245.00M(-125.2%)
-$11.28B(+5.9%)
May 2024
-
$971.00M(-107.9%)
-$10.65B(-5.2%)
Feb 2024
-
-$12.36B(-3562.7%)
-$11.23B(-560.7%)
Nov 2023
-
$357.00M(-7.3%)
$2.44B(-194.3%)
Aug 2023
-$2.58B(-140.5%)
$385.00M(-0.8%)
-$2.58B(-17.5%)
May 2023
-
$388.00M(-70.3%)
-$3.13B(+6.1%)
Feb 2023
-
$1.31B(-128.0%)
-$2.95B(+9.8%)
Nov 2022
-
-$4.67B(+2727.3%)
-$2.69B(-142.2%)
Aug 2022
$6.38B(+30.8%)
-$165.00M(-129.0%)
$6.37B(-20.8%)
May 2022
-
$568.00M(-63.8%)
$8.05B(-13.3%)
Feb 2022
-
$1.57B(-64.3%)
$9.29B(+0.2%)
Nov 2021
-
$4.40B(+190.8%)
$9.27B(+90.2%)
Aug 2021
$4.87B(+63.2%)
$1.51B(-16.0%)
$4.87B(+8.5%)
May 2021
-
$1.80B(+15.7%)
$4.49B(+208.6%)
Feb 2021
-
$1.56B(>+9900.0%)
$1.46B(-6.4%)
Nov 2020
-
$4.00M(-99.6%)
$1.56B(-49.4%)
Aug 2020
$2.99B(-57.6%)
$1.13B(-191.6%)
$3.08B(-1.8%)
May 2020
-
-$1.24B(-174.6%)
$3.13B(-50.1%)
Feb 2020
-
$1.66B(+8.6%)
$6.28B(-5.7%)
Nov 2019
-
$1.52B(+28.5%)
$6.66B(-5.5%)
Aug 2019
$7.05B(-15.7%)
$1.19B(-37.8%)
$7.05B(-13.5%)
May 2019
-
$1.91B(-6.4%)
$8.15B(-1.6%)
Feb 2019
-
$2.04B(+6.3%)
$8.28B(-4.5%)
Nov 2018
-
$1.92B(-16.3%)
$8.68B(+3.8%)
Aug 2018
$8.36B(+16.1%)
$2.29B(+12.3%)
$8.36B(+9.9%)
May 2018
-
$2.04B(-16.1%)
$7.61B(+1.6%)
Feb 2018
-
$2.43B(+51.8%)
$7.49B(+8.0%)
Nov 2017
-
$1.60B(+4.3%)
$6.93B(-3.7%)
Aug 2017
$7.20B(-3.5%)
$1.53B(-20.1%)
$7.20B(-4.2%)
May 2017
-
$1.92B(+2.5%)
$7.52B(-1.1%)
Feb 2017
-
$1.88B(+0.5%)
$7.60B(+0.9%)
Nov 2016
-
$1.87B(+0.9%)
$7.53B(+1.0%)
Aug 2016
$7.46B(-2.6%)
$1.85B(-7.8%)
$7.46B(+18.4%)
May 2016
-
$2.01B(+11.2%)
$6.30B(-4.4%)
Feb 2016
-
$1.81B(+0.7%)
$6.59B(-16.3%)
Nov 2015
-
$1.79B(+159.1%)
$7.88B(+2.9%)
Aug 2015
$7.66B(+52.3%)
$692.00M(-69.9%)
$7.66B(+2.2%)
May 2015
-
$2.30B(-25.7%)
$7.50B(+12.2%)
Feb 2015
-
$3.09B(+96.8%)
$6.68B(+31.6%)
Nov 2014
-
$1.57B(+196.6%)
$5.08B(+1.8%)
Aug 2014
$5.03B(-8.5%)
$530.00M(-64.3%)
$4.99B(-17.0%)
May 2014
-
$1.49B(-0.2%)
$6.00B(+1.7%)
Feb 2014
-
$1.49B(+0.5%)
$5.91B(-0.9%)
Nov 2013
-
$1.48B(-4.4%)
$5.96B(+8.4%)
Aug 2013
$5.50B(+18.7%)
$1.55B(+11.8%)
$5.50B(+13.5%)
May 2013
-
$1.39B(-10.1%)
$4.84B(+4.7%)
Feb 2013
-
$1.54B(+51.5%)
$4.63B(+3.4%)
Nov 2012
-
$1.02B(+13.6%)
$4.47B(-3.4%)
Aug 2012
$4.63B(-15.1%)
$896.00M(-23.4%)
$4.63B(-12.4%)
May 2012
-
$1.17B(-15.8%)
$5.29B(-1.0%)
Feb 2012
-
$1.39B(+17.9%)
$5.34B(-1.4%)
Nov 2011
-
$1.18B(-24.3%)
$5.41B(-0.7%)
Aug 2011
$5.45B(+21.5%)
$1.55B(+27.4%)
$5.45B(+11.1%)
May 2011
-
$1.22B(-16.6%)
$4.91B(+2.7%)
Feb 2011
-
$1.46B(+20.5%)
$4.78B(+2.8%)
Nov 2010
-
$1.21B(+20.2%)
$4.65B(+3.6%)
Aug 2010
$4.49B(+6.3%)
$1.01B(-7.5%)
$4.49B(+1.7%)
May 2010
-
$1.09B(-18.1%)
$4.42B(-0.4%)
Feb 2010
-
$1.33B(+26.6%)
$4.43B(+1.4%)
Nov 2009
-
$1.05B(+12.6%)
$4.37B(+3.5%)
Aug 2009
$4.22B(-1.4%)
$936.00M(-15.7%)
$4.22B(-0.2%)
May 2009
-
$1.11B(-12.7%)
$4.23B(-0.4%)
Feb 2009
-
$1.27B(+40.4%)
$4.24B(-0.4%)
Nov 2008
-
$905.00M(-4.0%)
$4.26B(-0.4%)
Aug 2008
$4.28B(+11.9%)
$943.00M(-16.2%)
$4.28B(+3.9%)
May 2008
-
$1.13B(-12.8%)
$4.12B(+2.3%)
Feb 2008
-
$1.29B(+39.8%)
$4.03B(+2.8%)
Nov 2007
-
$923.00M(+17.8%)
$3.92B(+2.4%)
Aug 2007
$3.83B(+16.9%)
$783.50M(-24.1%)
$3.83B(-0.3%)
May 2007
-
$1.03B(-12.5%)
$3.84B(+5.1%)
Feb 2007
-
$1.18B(+41.7%)
$3.65B(+6.4%)
Nov 2006
-
$832.10M(+4.7%)
$3.43B(+4.8%)
Aug 2006
$3.27B(+12.6%)
$794.70M(-5.9%)
$3.27B(+5.4%)
May 2006
-
$844.60M(-12.0%)
$3.11B(+6.9%)
Feb 2006
-
$959.60M(+42.2%)
$2.91B(+6.9%)
Nov 2005
-
$674.80M(+7.4%)
$2.72B(+6.6%)
Aug 2005
$2.91B(+14.2%)
$628.10M(-2.5%)
$2.55B(+4.1%)
May 2005
-
$644.10M(-16.4%)
$2.45B(+4.4%)
Feb 2005
-
$770.90M(+52.3%)
$2.35B(+4.3%)
Nov 2004
-
$506.10M(-4.1%)
$2.25B(+4.7%)
DateAnnualQuarterlyTTM
Aug 2004
$2.55B(+15.3%)
$527.90M(-2.4%)
$2.15B(+3.5%)
May 2004
-
$541.00M(-19.7%)
$2.07B(+4.0%)
Feb 2004
-
$674.00M(+66.4%)
$1.99B(+4.2%)
Nov 2003
-
$405.00M(-10.9%)
$1.91B(+2.8%)
Aug 2003
$2.21B(+14.3%)
$454.30M(-1.4%)
$1.86B(+3.3%)
May 2003
-
$460.70M(-22.3%)
$1.80B(+2.7%)
Feb 2003
-
$593.20M(+68.2%)
$1.75B(+4.1%)
Nov 2002
-
$352.70M(-10.6%)
$1.68B(+3.7%)
Aug 2002
$1.93B(+15.8%)
$394.70M(-4.7%)
$1.62B(+3.6%)
May 2002
-
$414.10M(-20.9%)
$1.57B(+4.6%)
Feb 2002
-
$523.40M(+79.2%)
$1.50B(+4.6%)
Nov 2001
-
$292.00M(-13.7%)
$1.43B(+2.5%)
Aug 2001
$1.67B(+14.7%)
$338.30M(-2.1%)
$1.40B(+2.1%)
May 2001
-
$345.50M(-24.4%)
$1.37B(+2.4%)
Feb 2001
-
$456.90M(+77.4%)
$1.34B(+5.2%)
Nov 2000
-
$257.60M(-16.9%)
$1.27B(+3.9%)
Aug 2000
$1.45B(+18.7%)
$309.90M(-0.9%)
$1.22B(+4.2%)
May 2000
-
$312.80M(-20.0%)
$1.17B(+5.1%)
Feb 2000
-
$391.20M(+86.1%)
$1.12B(+5.8%)
Nov 1999
-
$210.20M(-19.3%)
$1.06B(+4.1%)
Aug 1999
$1.23B(+19.6%)
$260.40M(+1.6%)
$1.02B(+5.3%)
May 1999
-
$256.30M(-22.3%)
$964.40M(+5.7%)
Feb 1999
-
$330.00M(+95.6%)
$912.10M(+6.0%)
Nov 1998
-
$168.70M(-19.4%)
$860.60M(+3.1%)
Aug 1998
$1.02B(+17.4%)
$209.40M(+2.6%)
$834.90M(+4.7%)
May 1998
-
$204.00M(-26.8%)
$797.20M(+3.7%)
Feb 1998
-
$278.50M(+94.8%)
$768.50M(+5.3%)
Nov 1997
-
$143.00M(-16.7%)
$729.50M(+2.9%)
Aug 1997
$872.60M(+16.1%)
$171.70M(-2.1%)
$708.80M(+3.8%)
May 1997
-
$175.30M(-26.8%)
$682.70M(+4.1%)
Feb 1997
-
$239.50M(+95.8%)
$655.70M(+5.3%)
Nov 1996
-
$122.30M(-16.0%)
$622.60M(+3.1%)
Aug 1996
$751.40M(+15.3%)
$145.60M(-1.8%)
$604.10M(+3.9%)
May 1996
-
$148.30M(-28.1%)
$581.70M(+3.7%)
Feb 1996
-
$206.40M(+98.8%)
$561.10M(+4.7%)
Nov 1995
-
$103.80M(-15.7%)
$536.10M(+3.1%)
Aug 1995
$651.60M(+13.6%)
$123.20M(-3.5%)
$520.20M(+2.1%)
May 1995
-
$127.70M(-29.6%)
$509.60M(+2.7%)
Feb 1995
-
$181.40M(+106.4%)
$496.10M(+5.0%)
Nov 1994
-
$87.90M(-21.9%)
$472.30M(+3.6%)
Aug 1994
$573.80M(+12.3%)
$112.60M(-1.4%)
$455.80M(+3.9%)
May 1994
-
$114.20M(-27.5%)
$438.70M(+2.7%)
Feb 1994
-
$157.60M(+120.7%)
$427.30M(+3.8%)
Nov 1993
-
$71.40M(-25.2%)
$411.60M(+1.3%)
Aug 1993
$510.90M(+13.4%)
$95.50M(-7.1%)
$406.20M(+3.1%)
May 1993
-
$102.80M(-27.6%)
$394.10M(+3.0%)
Feb 1993
-
$141.90M(+115.0%)
$382.70M(+4.6%)
Nov 1992
-
$66.00M(-20.9%)
$365.70M(+2.0%)
Aug 1992
$450.60M(+11.1%)
$83.40M(-8.8%)
$358.50M(+2.3%)
May 1992
-
$91.40M(-26.8%)
$350.50M(+3.3%)
Feb 1992
-
$124.90M(+112.4%)
$339.20M(+3.7%)
Nov 1991
-
$58.80M(-22.0%)
$327.00M(+1.8%)
Aug 1991
$405.50M(+14.4%)
$75.40M(-5.9%)
$321.10M(-3.3%)
May 1991
-
$80.10M(-28.9%)
$332.00M(-2.3%)
Feb 1991
-
$112.70M(+113.0%)
$339.70M(-1.2%)
Nov 1990
-
$52.90M(-38.7%)
$343.70M(-3.0%)
Aug 1990
$354.60M(+11.8%)
$86.30M(-1.7%)
$354.40M(-110.1%)
May 1990
-
$87.80M(-24.8%)
-$3.52B(+56.0%)
Feb 1990
-
$116.70M(+83.5%)
-$2.25B(+152.0%)
Nov 1989
-
$63.60M(-101.7%)
-$894.60M(-452.9%)
Aug 1989
$317.30M(+11.9%)
-$3.79B(-380.3%)
$253.50M(-56.4%)
May 1989
-
$1.35B(-8.5%)
$581.70M(+30.2%)
Feb 1989
-
$1.48B(+21.9%)
$446.90M(+39.2%)
Nov 1988
-
$1.21B(-135.0%)
$321.10M(+43.2%)
Aug 1988
$283.60M(+7.3%)
-$3.46B(-384.3%)
$224.20M(-67.3%)
May 1988
-
$1.22B(-10.0%)
$685.80M(+26.8%)
Feb 1988
-
$1.35B(+21.2%)
$540.70M(+48.1%)
Nov 1987
-
$1.11B(-137.2%)
$365.20M(+73.3%)
Aug 1987
$264.40M(+10.0%)
-$3.00B(-379.8%)
$210.70M(-68.5%)
May 1987
-
$1.07B(-8.9%)
$669.20M(+30.6%)
Feb 1987
-
$1.18B(+22.4%)
$512.30M(+51.0%)
Nov 1986
-
$960.30M(-137.8%)
$339.20M(+72.5%)
Aug 1986
$240.40M(+13.3%)
-$2.54B(-377.6%)
$196.60M(-62.8%)
May 1986
-
$913.90M(-8.8%)
$528.60M(+29.8%)
Feb 1986
-
$1.00B(+22.6%)
$407.30M(+45.3%)
Nov 1985
-
$817.70M(-137.1%)
$280.30M(+57.6%)
Aug 1985
$212.20M(+17.0%)
-$2.21B(-378.2%)
$177.80M(-62.6%)
May 1985
-
$792.60M(-9.4%)
$475.50M(+29.2%)
Feb 1985
-
$875.30M(+22.4%)
$367.90M(+44.3%)
Nov 1984
-
$715.20M(-137.5%)
$255.00M(-155.4%)
Aug 1984
$181.40M
-$1.91B(-378.5%)
-$460.20M(-131.8%)
May 1984
-
$685.00M(-10.2%)
$1.45B(+89.8%)
Feb 1984
-
$762.40M
$762.40M

FAQ

  • What is Walgreens Boots Alliance annual EBITDA?
  • What is the all time high annual EBITDA for Walgreens Boots Alliance?
  • What is Walgreens Boots Alliance annual EBITDA year-on-year change?
  • What is Walgreens Boots Alliance quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Walgreens Boots Alliance?
  • What is Walgreens Boots Alliance quarterly EBITDA year-on-year change?
  • What is Walgreens Boots Alliance TTM EBITDA?
  • What is the all time high TTM EBITDA for Walgreens Boots Alliance?
  • What is Walgreens Boots Alliance TTM EBITDA year-on-year change?

What is Walgreens Boots Alliance annual EBITDA?

The current annual EBITDA of WBA is -$11.28B

What is the all time high annual EBITDA for Walgreens Boots Alliance?

Walgreens Boots Alliance all-time high annual EBITDA is $8.36B

What is Walgreens Boots Alliance annual EBITDA year-on-year change?

Over the past year, WBA annual EBITDA has changed by -$8.70B (-336.79%)

What is Walgreens Boots Alliance quarterly EBITDA?

The current quarterly EBITDA of WBA is -$3.51B

What is the all time high quarterly EBITDA for Walgreens Boots Alliance?

Walgreens Boots Alliance all-time high quarterly EBITDA is $4.40B

What is Walgreens Boots Alliance quarterly EBITDA year-on-year change?

Over the past year, WBA quarterly EBITDA has changed by +$8.86B (+71.64%)

What is Walgreens Boots Alliance TTM EBITDA?

The current TTM EBITDA of WBA is -$2.57B

What is the all time high TTM EBITDA for Walgreens Boots Alliance?

Walgreens Boots Alliance all-time high TTM EBITDA is $9.29B

What is Walgreens Boots Alliance TTM EBITDA year-on-year change?

Over the past year, WBA TTM EBITDA has changed by +$8.66B (+77.11%)
On this page